Navigation Links
VA Retains Facilities at Four Boston Campuses
Date:5/5/2008

Peake: VA Prepared for Future Needs of Veterans

WASHINGTON, May 5 /PRNewswire-USNewswire/ -- After a detailed three-year study, the Department of Veterans Affairs (VA) has decided it will continue to provide services at its four Boston-area campuses -- Bedford, Brockton, Jamaica Plain, and West Roxbury.

"The potential benefits to be gained from any consolidation do not justify the disruption to veterans or to our first-class health care system in Boston," said Secretary of Veterans Affairs Dr. James B. Peake. "For the future, VA is prepared to provide health care for Boston veterans at its current four campuses."

In 2006, former VA Secretary James Nicholson rejected consolidation of all Boston health care services at one location, but selected for further study the possibility that Bedford's services could be moved to the Brockton campus, and that VA's Jamaica Plain and West Roxbury might be consolidated.

These options were investigated thoroughly, along with another more limited transfer of Bedford's services to Brockton that would have retained nursing home and outpatient services at the Bedford campus. VA's review of these options found there was no convincing data that consolidations would significantly improve quality of care, access, or achieve significant financial savings at this time.

"The process ensured veterans and other stakeholders' issues were fully reviewed in great detail," Peake added.

In announcing his decision, the VA secretary said there may be opportunities at the existing campuses for reuse of vacant land and buildings to provide benefits to veterans.

"Opportunities may be available for housing homeless veterans, assisted living facilities, geriatric continuing care communities and affordable housing for veterans through VA's Enhanced-Use Leasing program," Peake said.

VA will continue to strategically plan for the needs of veterans in the Boston area, taking into ac
'/>"/>

SOURCE U.S. Department of Veterans Affairs
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Assured Pharmacy Retains Empire Financial Group
2. Sunnylife Global Retains The Blaine Group For Investor Relations, Financial Public Relations
3. Bioponic Phytoceuticals Retains OTC Financial Network for Investor Relations
4. MaxLife Fund Corp. retains the Law firm, Anslow & Jaclin, LLP of Manalapan, N.J., to review MaxLife Fund Corp. options to be listed on the NASDAQ Capital Market
5. Genesis Technology Group Retains CCG Elite
6. The Ultimate Stress Reliever, SpaCapsule(R), the Capsule that Takes You on a Rejuvenating Journey to the Spa, Retains TransMedia Group for Soothing PR
7. QMed, Inc. Retains Lazard Middle Market
8. Big A Drug Stores, Inc. Retains DJM Realty to Dispose of All Stores Operating Under the Names of Drug Emporium, Big A, Camelot, Drug Fair and Drug Barn
9. Diagnostic Centers of America Retains NewsMark Public Relations to Showcase Its Rise as Only Medical Facility in South Florida With Worlds Most Advanced Cardiac Scanner
10. Leading Cosmetic Dermatologist, Peter G. Ballas II MD, Retains Kay Renz Public Relations to Promote his Practice and New Skincare Line
11. SpectraScience, Inc. Retains Hayden Communications
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2008)...tering recipes to cut fat, salt a quick fix withou..., Nov. 22 (HealthDay News) -- You can eat healthie...ng good food choices, say experts with the Texas A... reduce the sugar, fat or salt content of almost a...in taste, nutrition specialist Mary Bielamowicz sa...
(Date:11/21/2008)...nding may lead to new therapies for preterm labor ...Researchers say they,ve found the switch that acti...hildbirth, a finding that may lead to therapies fo...ormally binds the protein IP on the surface of the...nactive during pregnancy. , But researchers fr...
(Date:11/21/2008)...OUSTON(Nov. 21, 2008)The University of Texas Healt...ram, Training Excellence in Aging Studies (TEXAS),...ough a prestigious $2 million award from the Donal...hing funds., "This will allow us to teach geriatr...unior medical student to practicing physicians. Wi...
(Date:11/21/2008)...LINGTON, Va., Nov. 21 T...ased the following statement today from,GPhA Pres...l Trade Commission,(FTC) roundtable on "Emerging ... "The mere fact that the FTC is conducting thi...hind ensuring that consumers have access to safe a...
Breaking Medicine News(10 mins):Health News:Substitutions Make Holiday Fare Healthier 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:GPhA Statement on FTC Roundtable on Biogenerics 2
...nding every waking hour in front of the computer s...in the new year is out of the window and no sooner...While you recline and read this piece, the America...nactive’ trend is disastrous for your heart. ‘Get ...
...h minimal side effects - Scientists of a consortiu... Greece, has been awarded a grant from the Europea...very and validation of new therapeutic strategies ...-named Apotherapy, will develop methods to activat...
... think this piece of news is science fiction; now,...s with the desired characteristics- hair color, ey... advance. The Abraham Center of Life in San Anton...those couples, who are unable to have a biological...
... muscular dystrophy should avoid over exercising, ... or legs after exercise can be caused due to train...essional Association of Neurologists. Muscular dys... that causes progressive muscle weakness and over ...
Other Medicine News:
(Date:11/19/2008)...e/ -- Posit Science Corporation,researcher, Dan T...science,Annual Conference in Washington, DC this ...it Baby Boomers. The computerized brain plasticit...exercises that target auditory and,language syste...ed,improvements in cognition by improving speed a...
(Date:11/19/2008)... statistical significance , , ISELIN, N.J.,...ation (Nasdaq: PARS ) today announced results fr...Emulsion (NE) drug delivery technology formulated ...multi-center, randomized, double-blinded, placebo-... of the Company,s 3% Diclofenac Diethanolamine Nan...
(Date:11/19/2008)...wswire/ -- Biotech scientists increasingly are app... to better understand the effects of novel drug ca...enetic Engineering & Biotechnology News ( GEN... a new compound,s mechanism of action and eventual...ccording to the November 15 issue of GEN . ( http...
(Date:11/19/2008)... Roche- , , MONTVALE, N.J., Nov. 19 /PRNews...asdaq: MEMY ) today announced that it has achiev...487/MEM 3454, its lead alpha-7 nicotinic receptor ...chizophrenia (CIAS). The Company has randomized 2...0 million payment from its partner Roche. Memory ...
Breaking Medicine Technology:New Evidence That Brain-Plasticity Based Training has Broad Impact: Improved Cognition in Boomers, Improved Motor Control in Older Adults 2Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2GEN Reports on the Trend Toward Predictive Toxicogenomics 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 2Memory Pharmaceuticals Achieves Enrollment Goal for Phase 2 Study of MEM 3454 in Cognitive Impairment Associated With Schizophrenia 3Skystar Bio Pharmaceutical Announces Upcoming Interview With WallSt net 28 www wallst net 29 4134 1Skystar Bio Pharmaceutical Announces Upcoming Interview With WallSt net 28 www wallst net 29 4134 2Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 1370 1Use of Fractional Flow for Optimizing Patient Outcomes is Topic of Several Sessions at TCT 2007 1370 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 1Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 2Simcere Pharmaceutical Group to Announce Third Quarter 2007 Earnings on Monday November 5 2007 1368 3Xytis Names Gordon H Busenbark as Chief Financial Officer 576 1Xytis Names Gordon H Busenbark as Chief Financial Officer 576 2
...-AstraZeneca today announced clinical,trial data f...ine,fumarate sustained release), at the European C...monstrated that the SEROQUEL®,sustained releas...se), administered once daily, significantly improv...d by PANSS) and increased the,time to psychiatric ...
...NESS WIRE)--Mar 20, 2007 - Calando,Pharmaceuticals...ity-owned subsidiary of Arrowhead Research Corpora...he Proceedings of the,National Academy of Sciences... first non-human primate study to use multiple, sy...c candidate that is a,nanoparticle containing non-...
Other Medicine Technology:Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 2Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 3Seroquel Sustained Release Schizophrenia Data Presented at ECP,Congress in Madrid 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 2Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 3Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 4Calando Pharmaceuticals Publishes the First Non-Human Primate Study,on Targeted, Systemic Delivery of siRNA in National Academy of,Sciences Journal 5
Zeiss offers a full range of filter sets for a variety of applications.
Dust covers for a variety of Zeiss microscopes
These objectives have more contrast than the DLL objectives for enhanced contrast with tissue culture specimens. These objectives are designed for use on inverted microscopes and therefore their mark
...that offers you much more than you have ever expec...e impressed by the outstanding quality, and functi... work as easy and safe as possible thus increasin... more time for the observation. , Contrasting...
Medicine Products: